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Background. The use of donation after circulatory death (DCD) donors for lung 
transplantation has come into practice. This study investigated whether DCD lungs 
can be resuscitated after warm ischemia with normothermic ex vivo lung perfusion 
(EVLP).    
Methods. Four hours after cardiac arrest, beagles were divided into 2 groups (n=6 
each): those with static cold storage (SCS group) or normothermic EVLP (EVLP 
group) for 3.5 h. The physiological lung functions were evaluated during EVLP. In 
both groups, the left lungs were then transplanted and reperfused for 4 h to 
evaluate the posttransplant lung functions. The lung tissue adenosine triphosphate 
(ATP) levels were measured at given time points. 
Results. Lung oxygenation was significantly improved with EVLP (p < 0.01), and 
lung oxygenation at the end of EVLP significantly reflected the posttransplant lung 
oxygenation (r = 0.99, p < 0.01). The posttransplant lung oxygenation was 
significantly better in the EVLP group compared with the SCS group (p < 0.05). The 
dynamic pulmonary compliance and wet to dry lung weight ratio 4 h after 
transplantation were also significantly better in the EVLP group than in the SCS 
group (p < 0.05). Microthrombi in the donor lungs before transplantation were 
microscopically detected more often in the SCS group. The lung tissue ATP levels 4 
h after transplantation were significantly higher in the EVLP group compared with 
the SCS group (p = 0.03). 
Conclusions. Normothermic ex vivo lung perfusion could resuscitate DCD lungs 






There has been a progressive increase in the number of patients on the waiting list, 
which continually exceeds the number of available organs. The use of DCD donors 
has been employed to resolve this problem (1-5). Severe warm ischemia reperfusion 
injury may lead to primary graft dysfunction, and remains a significant cause of 
early morbidity and mortality after lung transplantation (6,7). The inhibition of 
warm ischemia reperfusion injury is, therefore, crucial to facilitate lung 
transplantation from DCD donors. 
    The principle of EVLP is to recreate the physiological environment by 
maintaining normothermia and providing the essential substrates for cellular 
metabolism. Therefore, EVLP enables organ viability assessment, prolonged 
preservation, and resuscitation from injuries before transplantation. Steen and 
colleagues developed an ex vivo system for evaluating the functions of DCD lungs 
before transplantation, and successfully performed lung transplantation from an 
uncontrolled DCD donor in 2000 (8). Cypel and colleagues established a successful 
prolonged EVLP system (9). EVLP can also provide access for the administration of 
cytoprotective and immunomodulatory drugs, and can allow for both the 
pretreatment and reconditioning of marginal donor lungs (10).  
     We simulated a clinically relevant uncontrolled DCD model in the current 
study. We have previously reported the protective effects of nitroglycerin (NTG) and 
dibutyryl cyclic adenosine monophosphate (db-cAMP) for ischemia reperfusion 
injury (11-13). In this study, we investigated whether EVLP using the STEEN 
solution with NTG and db-cAMP would resuscitate DCD lungs after warm ischemia, 
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and would ameliorate ischemia reperfusion injury.  
 
Materials and Methods 
Animals 
Beagles weighting from 9 to 15 kg (Kitayama Labes Co. Ltd., Hongo Farm, 
Yamaguchi, Japan) were used in this study. All animals received humane care in 
compliance with the Principals of Laboratory Animal Care, formulated by the 
United States National Society for Medical Research, and the Guide for the Care 
and Use of Laboratory Animals, prepared by the US Institute of Laboratory Animal 
Resources and published by the National Institutes of Health (NIH Publication 
85-23, revised 1996). The study was approved by the Ethics Committee of the 
Faculty of Medicine at Kyoto University, Japan. 
 
Study design 
The beagles were anesthetized with an intramuscular injection of midazolam (0.5 
mg/kg), xylazine (0.25 mg/kg), and atropine sulfate (0.05 mg/kg). The animals were 
intubated and ventilated with an inspired oxygen fraction (FiO2) of 1.0, a tidal 
volume of 25 ml/kg, a frequency of 15 breaths/min, and a positive end-expiratory 
pressure (PEEP) of 5 cmH2O. Cardiac arrest was induced by the intravenous 
injection of potassium chloride (0.5 mEq/kg) without heparinization. The chest was 
opened before cardiac arrest to collect the lung tissue biopsies and was kept open 
during 4 h of warm ischemia. The tracheal tube was disconnected from the 
ventilator and left open to the air after cardiac arrest. Therefore, the donor lungs 
kept collapsed completely during 4 h of warm ischemia. Four hours after cardiac 
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arrest, the mechanical ventilation was resumed as described above, the main 
pulmonary artery was cannulated, the superior and inferior vena cava were tied, 
and the left atrial appendage was incised. Antegrade and retrograde flushes of the 
lungs were performed with 1,000 ml and 500 ml of ET-Kyoto solution (Otsuka 
Pharmaceutical Factory Inc, Tokushima, Japan), respectively. After the donor lungs 
were retrieved, they were divided into 2 groups (n=6 each): static cold storage with 
ET-Kyoto solution at 4℃ for 3.5 h (SCS group) or normothermic EVLP for 3.5 h 
(EVLP group). In both groups, the left lung was then transplanted to a recipient. 
The bronchial anastomosis was performed first with a running 5-0 PDS suture, the 
left atrial anastomosis was performed next with a running 6-0 prolene suture, and 
then the pulmonary arterial anastomosis was performed with a running 6-0 prolene 
suture. The implantation time was set for 60 min. After the transplanted lung was 
reinflated and mechanically ventilated as described above, the PA clamp was 
gradually removed and the transplanted lung was reperfused for 4 h to evaluate the 
posttransplant lung functions. The right pulmonary artery was occluded with a 
tourniquet at 45 min of reperfusion to specifically evaluate the functions of the 
transplanted lung.  
 
Ex vivo lung perfusion (EVLP) 
EVLP was performed as described by Cypel and colleagues (14). The lungs were 
placed in the XVIVO chamber (Vitrolife, Denver, CO). The trachea was intubated 
and connected to the ventilator. The pulmonary artery and left atrial appendage 
were cannulated directly and connected to the perfusion circuit. The EVLP 
perfusate consisted of STEEN solution (1,500 ml) with methylprednisolone (500 mg), 
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heparin (10,000 IU), cefazolin (500 mg), db-cAMP (1,500 mg), and NTG (75 mg). The 
perfusate was driven by a centrifugal pump at a constant flow rate. The perfusate 
flow was initiated at 10% of the full flow rate at room temperature. The 
temperature of the perfusate was gradually increased to 37℃ . When the 
temperature of the perfusate reached 32℃, ventilation was started with a FiO2 of 
0.21, tidal volume of 10 ml/kg, frequency of 10 breaths/min and PEEP of 5 cmH2O, 
and the deoxygenation of the perfusate from the lungs was started with a gas 
mixture of nitrogen (86%), carbon dioxide (8%), and oxygen (6%). The perfusate flow 
rate was gradually increased to the full flow rate which was 40% of estimated 
cardiac output (CO = 100 ml/kg). EVLP at the full flow rate was conducted for 90 
min. The time point at which the perfusion flow reached the full flow rate was 
defined as the base line (BL), and the physiological lung functions during EVLP 
were evaluated every 30 min. The pulmonary arterial pressure, left atrial pressure, 
and peak airway pressure were all continuously monitored, and the left atrial 
pressure was maintained at 3 to 5 mmHg throughout the experiments. Dynamic 
pulmonary compliance was defined as tidal volume/(PawP－PEEP) (ml/cmH2O). A 
blood gas analysis of the perfusate to and from the lungs was performed every 30 
min after 10 min exposure to FiO2 of 1.0. The temperature of the perfusate was 
cooled down to 20℃ after the last evaluation, and then perfusion and ventilation 
were stopped. The donor lungs semiinflated with air were then stored in ET-Kyoto 
solution at 4℃ until transplantation.  
 
Posttransplant lung functions 
The pulmonary arterial pressure and peak airway pressure were continuously 
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monitored throughout the experiments. Dynamic pulmonary compliance was 
defined as described above. A blood gas analysis was performed from the femoral 
artery and pulmonary artery at given time points. Lung tissue biopsy samples 
collected from the left lower lobe 4 h after transplantation were weighed as the wet 
lung weight, placed in an oven at 180℃ for 24 h, and then reweighed as the dry 
lung weight. The wet to dry lung weight ratio was calculated to evaluate the 
presence of lung edema.  
 
Histological evaluation of microthrombi before transplantation and ischemia 
reperfusion injury 
Lung tissue biopsies were collected from the right upper lobe before transplantation 
and the left upper lobe 4 h after transplantation to microscopically evaluate the 
formation of microthrombi in the donor lungs before transplantation and ischemia 
reperfusion injury after transplantation. They were fixed in 10% buffered formalin, 
embedded in paraffin, and stained with hematoxylin and eosin. Ischemia 
reperfusion injury was scored blindly by two investigators (D.N. and J.S.) using a 
four-point scale according to the combined assessment of edema (interstitial and 
intra-alveolar congestion), hemorrhage, inflammatory cell infiltration, and hyaline 
membrane formation: 0 = absent, 1 = mild, 2 = moderate, 3 = severe damage (15,16).  
 
Lung tissue energy levels 
Lung tissue biopsies were collected from the right lower lobe before cardiac arrest 
and after warm ischemia, and then were collected from the left lower lobe 4 h after 
transplantation. The levels of adenosine triphosphate (ATP) were measured by 
8 
 
high-performance liquid chromatography using a Shim-pack CLC-ODS column (15 
cm×6.0 mm; Shimadzu, Japan) and 100 mM sodium phosphate buffer (PH 6.0) at a 
wavelength of 260 nm, as previously described (17).  
 
Statistical analysis 
All data are presented as the means ± standard deviation. The statistical analysis 
was performed by Student's t-test, the Mann-Whitney U test, and the χ2 test. A p 
value less than 0.05 was considered to be statistically significant.  
 
Results 
Physiological lung functions  
One beagle died due to severe pulmonary edema 2.5 h after transplantation in each 
group. These two animals were excluded from the data analysis 3 h and 4 h after 
transplantation.  
     Lung oxygenation was significantly improved by EVLP (p < 0.01; Figure 1A). 
In detail, the PaO2 at the baseline of EVLP and the end of EVLP were 437 ± 68 
mmHg and 558 ± 35 mmHg, respectively. The dynamic pulmonary compliance 
and pulmonary vascular resistance were stable during EVLP (Figures 1B and C). 
     The posttransplant lung oxygenation was significantly better in the EVLP 
group than that in the SCS group 3 h and 4 h after transplantation (p < 0.05; Figure 
2A). The dynamic pulmonary compliance 4 h after transplantation was significantly 
better in the EVLP group than that in the SCS group (EVLP group 13.02 ± 0.99 
ml/cmH2O, SCS group 11.26 ± 0.99 ml/cmH2O; p < 0.05; Figure 2B). The wet to 
dry lung weight ratio 4 h after transplantation was also significantly lower in the 
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EVLP group than that in the SCS group (EVLP group 6.30 ± 0.54, SCS group 
10.92 ± 0.86; p < 0.01; Figure 2C).  
     The lung oxygenation at the end of EVLP was significantly correlated with the  
lung oxygenation 4 h after transplantation (r = 0.99, p < 0.01; Figure 3A). However, 
there was no significant correlation between the dynamic pulmonary compliance at 
the end of EVLP and that 4 h after transplantation (r = 0.55, p = 0.33; Figure 3B).  
 
Histological findings of ischemia reperfusion injury  
Severe interstitial and intra-alveolar edema, hemorrhage, infiltration or 
aggregation of inflammatory cells in the air space or vessel wall, and hyaline 
formation were detected in the SCS group 4 h after transplantation (Figures 4A and 
B). The acute lung injury score was significantly lower in the EVLP group compared 
with the SCS group (EVLP group: 24.5 ± 3.1, SCS group: 32.3 ± 6.4, p=0.03; 
Figure 4C).  
 
The formation of microthrombi before transplantation  
In the macroscopic findings, the surface of donor lungs looked uniformly perfused 90 
min after EVLP (Figures 5A and B). In the donor lungs before transplantation, 
residual blood cells or blood clots were microscopically observed more often in the 
SCS group compared with the EVLP group (Figures 6A and B).  
 
Lung tissue energy level 
In the EVLP group, the lung tissue ATP levels which decreased during warm 
ischemia were improved to the normal levels observed before cardiac arrest 4 h 
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after transplantation (Figure 7). The lung tissue ATP levels 4 h after 
transplantation were significantly higher in the EVLP group compared with the 
SCS group (p = 0.03; Figure 7). The ATP levels before cardiac arrest and after warm 
ischemia were 3.27±0.37 and 1.67±0.55 nmol/mg, respectively. The ATP levels 4 h 
after transplantation in the EVLP group and in the SCS group were 3.27±0.54, and 
2.37±0.49 nmol/mg, respectively.  
 
Discussion 
This study demonstrated that normothermic EVLP with db-cAMP and NTG could 
resuscitate DCD lungs injured by 4 h of warm ischemia, and could ameliorate 
ischemia reperfusion injury compared with static cold storage. Cypel and colleagues 
have established a successful prolonged EVLP system using an acellular perfusate, 
and suggested that this system can be used to assess, maintain, and treat injured 
donor lungs (14). We also have adapted their technique, and confirmed excellent 
lung performance during 8 h of EVLP (unpublished data). The current study found 
that the lung oxygenation at the end of EVLP was significantly correlated with the 
lung oxygenation after transplantation, and thus our EVLP system can be useful to 
evaluate the oxygenation of DCD lungs before transplantation. Cypel and 
colleagues recently demonstrated in their clinical study that lung transplantation 
using high risk donor lungs that are stable physiologically during 4 h of EVLP led to 
results similar to conventional lung transplantation (18). In their study, lung 
oxygenation in high risk donor lungs was improved 1-2 h after EVLP. Steen and 
colleagues demonstrated that EVLP could be used for reconditioning of initially 
rejected donor lungs, and the median reconditioning time was 1 hour and 29 
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minutes (19). Therefore, in the current study, EVLP at a full flow rate was 
conducted for 1 hour 30 minutes. We found that the lung oxygenation was 
significantly improved by short-term EVLP, and that the other lung functions were 
stable during EVLP.  
     Intravascular pulmonary microthrombus formation, which results in an 
increase of intrapulmonary shunting, is one of the major causes of reperfusion 
injury in lung transplantation from DCD donors. The benefits of additional 
retrograde flush has been shown in experimental and clinical lung transplantation 
(20-23). In the current study, the donor lungs were macroscopically perfused 
uniformly by EVLP, although the surface of the donor lungs looked patchy after the 
antegrade and retrograde flushes. Furthermore, histological examination of the 
donor lungs before transplantation revealed fewer microthrombi in the EVLP group 
compared with the SCS group. These results indicated that some residual 
microthrombi wedged in the precapillary area after the antegrade and retrograde 
flushes were eliminated by EVLP. As a result, the intrapulmonary shunting in the 
donor lungs improved, and the lung oxygenation also significantly improved by 
EVLP.  
     EVLP can provide access for the administration of cytoprotective drugs, and 
can perform pretreatment and reconditioning of marginal donor lungs (24,25). In 
the current study, db-cAMP and NTG were included in the perfusate. A previous 
study demonstrated that the intracellular cAMP levels were decreased in DCD 
lungs (17). Db-cAMP elevates the intracellular levels of cAMP, which acts as a 
second messenger in suppressing vascular permeability, relaxing vascular smooth 
muscle, and suppressing neutrophil adhesion to the vascular wall (13). On the other 
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hand, NTG works in vivo as an NO donor. NO stimulates the production of cGMP, 
which acts as an intracellular second messenger for relaxing vascular smooth 
muscle, inhibiting platelet adhesion and aggregation, and adjusting the vascular 
permeability (12).  
     Oxidative energy production by mitochondrial electron transport would still be 
sustained to some extent at hypothermia. Therefore, lung cells are able to maintain 
aerobic metabolism using the oxygen present in the alveoli during preservation (26). 
In the SCS group, the lung ATP levels which decreased during warm ischemia were 
improved, but did not reach the normal levels after transplantation. EVLP washed 
out the residual microthrombi in the donor lungs, thus resulting in a more uniform 
distribution of the preservation solution, including nutrition. As a result, ATP 
synthesis was completely restored in the whole lung cells during normothermic 
EVLP, and the ATP levels decreased during warm ischemia were improved to the 
normal levels after transplantation. It might be easier to prove the metabolic 
benefits of EVLP, if the ATP levels after warm ischemia were compared to those at 
the end of EVLP. Energy charges maintain the homeostasis and structural 
competence of the vasculature and parenchymal cell interactions, and marginal 
donor lungs can maintain their integrity of the structural elements necessary to 
recover from various injuries.  
     This study had several limitations. First, although we simulated a clinically 
relevant uncontrolled DCD model, cardiac arrest was induced by the intravenous 
injection of potassium chloride. Such an abrupt cardiac arrest might be removed 
from the clinical reality in that there was not an agonal phase which is an almost 
invariable component of DCD. Second, EVLP was performed immediately after 
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organ retrieval. Clinical practice may require some additional time for donor lungs 
to be transported from a donor hospital to a transplant center. Thus, EVLP may be 
effective after static cold storage, just before lung transplantation in a transplant 
center. Third, the addition of db-cAMP and NTG in the perfusate resulted in an 
inability to conclusively prove that EVLP alone was responsible for all of the 
benefits observed in this study. How much these additional additives contributed to 
the benefits of EVLP would require further study. Finally, one beagle died due to 
pulmonary edema after transplantation in the EVLP group, as well as in the SCS 
group. The reason why EVLP could not resuscitate the donor lungs, and could not 
reduce the ischemia reperfusion injury in the fatal case therefore requires further 
study.  
     In conclusion, short-term EVLP washed out residual pulmonary microthrombi, 
and restored the lung tissue ATP levels which decreased during warm ischemia to 
the normal levels. As a result, DCD lungs could be resuscitated after warm ischemia, 













Figure 1. Physiological lung functions during 90 minutes of EVLP at the full flow 
rate. (BL = baseline, EVLP = ex vivo lung perfusion). * p < 0.01 between the lung 
oxygenation at the baseline of EVLP and that after 90 min of EVLP.  
 
Figure 2. Physiological lung functions after transplantation. (EVLP = ex vivo lung 
perfusion, SCS = static cold storage). (A) * p < 0.05 between the EVLP group (boxes) 
and the SCS group (open circles). (B) * p < 0.05 and ** p < 0.01.  
 
Figure 3. The correlation between the physiological lung functions at the end of 
EVLP and those 4 h after transplantation. (EVLP = ex vivo lung perfusion). (A) The 
lung oxygenation at the end of EVLP was significantly correlated with the lung 
oxygenation 4 h after transplantation (r = 0.99, p < 0.01). (B) There was no 
significant correlation between the dynamic pulmonary compliance at the end of 
EVLP and that 4 h after transplantation (r = 0.55, p = 0.33).  
 
Figure 4. The histological findings of ischemia reperfusion injury in the EVLP group 
(A) and the SCS group (B). (EVLP = ex vivo lung perfusion, SCS = static cold 
storage). (C) Ischemia reperfusion injury was scored using a four-point scale 
according to the combined assessment of edema, hemorrhage, inflammatory cell 
infiltration, and hyaline membrane formation. * p = 0.03.  
 
Figure 5. The macroscopic findings at the baseline of EVLP (A) and after 90 min of 




Figure 6. The formation of microthrombi in the donor lungs before transplantation 
in the EVLP group (A) and the SCS group (B). (EVLP = ex vivo lung perfusion, SCS 
= static cold storage). The arrows indicate residual intravascular microthrombi.  
 
Figure 7. Lung tissue ATP levels before cardiac arrest, after warm ischemia, and 4 h 
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